SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-22-022342
Filing Date
2022-11-07
Accepted
2022-11-07 08:30:59
Documents
68
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q rlyb-20220930.htm   iXBRL 10-Q 2851761
2 EX-31.1 rlyb-ex31_1.htm EX-31.1 21568
3 EX-31.2 rlyb-ex31_2.htm EX-31.2 21827
4 EX-32.1 rlyb-ex32_1.htm EX-32.1 12634
5 EX-32.2 rlyb-ex32_2.htm EX-32.2 12633
6 GRAPHIC img114781166_0.jpg GRAPHIC 8945
  Complete submission text file 0000950170-22-022342.txt   8181168

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT rlyb-20220930.xsd EX-101.SCH 42119
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT rlyb-20220930_def.xml EX-101.DEF 177874
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT rlyb-20220930_cal.xml EX-101.CAL 40310
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT rlyb-20220930_lab.xml EX-101.LAB 400668
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT rlyb-20220930_pre.xml EX-101.PRE 311378
62 EXTRACTED XBRL INSTANCE DOCUMENT rlyb-20220930_htm.xml XML 1258434
Mailing Address 234 CHURCH STREET SUITE 1020 NEW HAVEN CT 06510
Business Address 234 CHURCH STREET SUITE 1020 NEW HAVEN CT 06510 203- 859-3820
Rallybio Corp (Filer) CIK: 0001739410 (see all company filings)

IRS No.: 851083789 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40693 | Film No.: 221363859
SIC: 2834 Pharmaceutical Preparations